These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 117757)

  • 1. [Analysis on costs-benefits of vaccination against measles (author's transl)].
    Porro de' Somenzi C
    Ann Sclavo; 1979 Jun; 21 Suppl 1():373-6. PubMed ID: 117757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Costs and benefits of measles vaccination].
    Ambrosch F; Wiedermann G; Harasek G
    Fortschr Med; 1978 Feb; 96(8):409-14. PubMed ID: 415953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Organization of the campaign of measles vaccination (author's transl)].
    Volpato C
    Ann Sclavo; 1979 Jun; 21 Suppl 1():402-6. PubMed ID: 518152
    [No Abstract]   [Full Text] [Related]  

  • 4. [A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy].
    Vitale F; Barbieri M; Dirodi B; Vitali Rosati G; Franco E
    Ann Ig; 2013; 25(1):43-56. PubMed ID: 23435779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Status of immunity after measles vaccination (author's transl)].
    La Cauza C; Galluzzi F; Salti R
    Ann Sclavo; 1980; 22(4):545-54. PubMed ID: 7018418
    [No Abstract]   [Full Text] [Related]  

  • 6. [On vaccination against measles with a live and attenuated virus (Schwarz strain) in a nursery school. Resistance to natural infection (author's transl)].
    Nardi G; Battistini A; Mazzeo G; Tanzi ML; Grzincich GL
    Ann Sclavo; 1977; 19(6):1144-52. PubMed ID: 618060
    [No Abstract]   [Full Text] [Related]  

  • 7. [Measles vaccination with split vaccines and living vaccines (author's transl)].
    Stehr K; Enders-Ruckle G; Spiess H
    MMW Munch Med Wochenschr; 1975 Jul; 117(27):1159-64. PubMed ID: 808710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global eradication of measles: an epidemiologic and economic evaluation.
    Levin A; Burgess C; Garrison LP; Bauch C; Babigumira J; Simons E; Dabbagh A
    J Infect Dis; 2011 Jul; 204 Suppl 1():S98-106. PubMed ID: 21666220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health impact of measles vaccination in the United States.
    Bloch AB; Orenstein WA; Stetler HC; Wassilak SG; Amler RW; Bart KJ; Kirby CD; Hinman AR
    Pediatrics; 1985 Oct; 76(4):524-32. PubMed ID: 3931045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of vaccination policies. The case of measles].
    Lafarge H; Levy E; Rey M
    Rev Epidemiol Sante Publique; 1985; 33(3):182-93. PubMed ID: 4081224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Visiting health contribution to vaccination campaign against measles (author's transl)].
    Federico MR
    Ann Sclavo; 1979 Jun; 21 Suppl 1():407-9. PubMed ID: 518153
    [No Abstract]   [Full Text] [Related]  

  • 12. [Long-term-follow-up-study after measles-vaccination (author's transl)].
    Huber EG; Rannon L; Galffy G
    Padiatr Padol; 1976; 11(1):72-6. PubMed ID: 1250637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using cost-effectiveness analysis to support research and development portfolio prioritization for product innovations in measles vaccination.
    Garrison LP; Bauch CT; Bresnahan BW; Hazlet TK; Kadiyala S; Veenstra DL
    J Infect Dis; 2011 Jul; 204 Suppl 1():S124-32. PubMed ID: 21666153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of the incidence of measles in Bratislava before and after introduction of vaccination (author's transl)].
    Ferencei M; Holanová J; Dimitrova E
    Bratisl Lek Listy; 1976 Jun; 65(6):659-71. PubMed ID: 974833
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experiment of vaccination against measles using attenuated virus (Schwarz strain) (author's transl)].
    Trivello R; Renzulli G; Romano M; Milone G; Moschen ME
    Ann Sclavo; 1978; 20(2):113-20. PubMed ID: 742926
    [No Abstract]   [Full Text] [Related]  

  • 16. [The social impact of the vaccination against measles in Mexico. Comments during the course of the epidemics of 1988-1990].
    Cárdenas-Ayala VM; Sánchez-Vargas C
    Bol Med Hosp Infant Mex; 1990 Jul; 47(7):500-5. PubMed ID: 2206416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spotlight on measles 2010: Increased measles transmission in Ferrara, Italy, despite high vaccination coverage, March to May 2010: increased measles transmission in Ferrara, Italy, despite high vaccination coverage, March to May 2010.
    Cova M; Cucchi A; Turlà G; Codecà B; Buriani O; Gabutti G
    Euro Surveill; 2010 Dec; 15(50):. PubMed ID: 21172173
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost-effectiveness of workplace vaccination against measles.
    Coppeta L; Morucci L; Pietroiusti A; Magrini A
    Hum Vaccin Immunother; 2019; 15(12):2847-2850. PubMed ID: 31339463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-benefit studies of vaccinations in Finland.
    Elo O
    Dev Biol Stand; 1979; 43():419-28. PubMed ID: 118069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategic planning for measles control: using data to inform optimal vaccination strategies.
    Simons E; Mort M; Dabbagh A; Strebel P; Wolfson L
    J Infect Dis; 2011 Jul; 204 Suppl 1():S28-34. PubMed ID: 21666174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.